BioCryst Pharmaceuticals
BCRX
#4939
Rank
โ‚น179.15 B
Marketcap
โ‚น696.28
Share price
-2.10%
Change (1 day)
11.68%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2026 (TTM): -โ‚น129.74

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น126.17. In 2025 the company made an earnings per share (EPS) of โ‚น116.82 an increase over its 2024 EPS that were of -โ‚น40.19.

EPS history for BioCryst Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น129.74-211.05%
2025โ‚น116.82-390.7%
2024-โ‚น40.19-63.56%
2023-โ‚น110.28-11.28%
2022-โ‚น124.3029.13%
2021-โ‚น96.26-4.63%
2020-โ‚น100.9410.2%
2019-โ‚น91.590%
2018-โ‚น91.5925.64%
2017-โ‚น72.904%
2016-โ‚น70.0927.12%
2015-โ‚น55.14-13.24%
2014-โ‚น63.5523.64%
2013-โ‚น51.40-30.38%
2012-โ‚น73.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-โ‚น289.73 129.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น268.92-313.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚น245.80 94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-โ‚น18.69-85.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น142.06 12.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น406.55 222.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น41.12-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น297.20 135.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น471.04 273.33%๐Ÿ‡บ๐Ÿ‡ธ USA